FDA Drug Application (090793) for TRI-ESTARYLLA by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number090793
Product Number001
FormTABLET;ORAL-28
Dosage0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRI-ESTARYLLA
Active IngredientETHINYL ESTRADIOL; NORGESTIMATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORGESTIMATE23


Back to FDA Applications sponsored by SANDOZ